scholarly journals Psychometric validation of the Chinese version of the M. D. Anderson Symptom Inventory-Head and Neck Module in patients with nasopharyngeal carcinoma

Author(s):  
Wenli Xiao ◽  
Carmen W.H. Chan ◽  
Xin Shelley Wang ◽  
Jinnan Xiao ◽  
Marques S.N. Ng
2016 ◽  
Vol 51 (6) ◽  
pp. 1055-1061 ◽  
Author(s):  
Daniel Sánchez ◽  
Andrés Chala ◽  
Andrés Alvarez ◽  
Catalina Payan ◽  
Tito Mendoza ◽  
...  

2021 ◽  
pp. 1-9
Author(s):  
Mike K.T. Cheung ◽  
Sam C.C. Chan

BACKGROUND: Self-efficacy is a key psychosocial factor influencing the outcome of vocational rehabilitation programs. There is lack of a validated job-seeking self-efficacy measure for Chinese persons with disabilities. OBJECTIVE: The aim of this study was to validate the Chinese version of the Job-Seeking Self-Efficacy Scale (C-JSS) developed by Barlow, Wright, and Cullen (2002) and to examine its psychometric properties using a Chinese sample of persons with disabilities. METHODS: JSS was first translated into Chinese and reviewed by vocational rehabilitation practitioners and persons with disabilities. Ninety-seven Chinese participants with disabilities were recruited to fill in the questionnaire of JSS and other questions. The internal consistency, structural and coverage validities of C-JSS were evaluated. RESULTS: C-JSS showed a high internal consistency (Cronbach’s alpha = 0.95) and unidimensional factorial structure. For concurrent validity, there were significant correlations between C-JSS with the score of WHODAS 2.0 (p = 0.001), educational level (p <  0.001), job-seeking behavior (p = 0.031), and self-reported professional skills (p = 0.008). CONCLUSION: The results of this study provide preliminary evidence that C-JSS is a reliable and valid instrument to measure the self-efficacy of job-seeking behavior among a Chinese sample of persons with disabilities.


PLoS ONE ◽  
2014 ◽  
Vol 9 (1) ◽  
pp. e87024 ◽  
Author(s):  
Jing Yuan ◽  
David Ka Wai Yeung ◽  
Greta S. P. Mok ◽  
Kunwar S. Bhatia ◽  
Yi-Xiang J. Wang ◽  
...  

Nursing Open ◽  
2021 ◽  
Author(s):  
Tingting Cai ◽  
Qingmei Huang ◽  
Fulei Wu ◽  
Haozhi Xia ◽  
Changrong Yuan

1990 ◽  
Vol 104 (1) ◽  
pp. 41-42 ◽  
Author(s):  
S. Elango ◽  
C. R. Jayakumar

AbstractRecent reports have dispelled the previously held concept that head and neck cancer rarely metastases beyond the cervical lymph nodes. Nasopharyngeal cancer has been reported to have a higher incidence of distant metastases compared to other head and neck cancers, the common sites being bone, lung and liver. A case of nasopharyngeal carcinoma presenting as obstructive jaundice because of secondaries at the porta hepatis is presented here.


2016 ◽  
Vol 130 (S2) ◽  
pp. S97-S103 ◽  
Author(s):  
R Simo ◽  
M Robinson ◽  
M Lei ◽  
A Sibtain ◽  
S Hickey

AbstractThis is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. Although much commoner in the eastern hemisphere, with an age-standardised incidence rate of 0.39 per 100 000 population, cancers of the nasopharynx form one of the rarer subsites in the head and neck.1 This paper provides recommendations on the work up and management of nasopharyngeal cancer based on the existing evidence base for this condition.Recommendations• Patients with nasopharyngeal carcinoma (NPC) should be assessed with rigid and fibre-optic nasendoscopy. (R)• Nasopharyngeal biopsies should be preferably carried out endoscopically. (R)• Multislice computed tomographic (CT) scan of head, neck and chest should be carried out in all patients and magnetic resonance imaging (MRI) where appropriate to optimise staging. (R)• Radiotherapy (RT) is the mainstay for the radical treatment for NPC. (R)• Concurrent chemoradiotherapy offers significant improvement in overall survival in stage III and IV diseases. (R)• Surgery should only be used to obtain tissue for diagnosis and to deal with otitis media with effusion. (R)• Radiation therapy is the treatment of choice for stage I and II disease. (R)• Intensity modulated radiation therapy techniques should be employed. (R)• Concurrent chemotherapy with radiation therapy is the treatment of choice for stage III and IV disease. (R)• Patients with NPC should be followed-up and assessed with rigid and/or fibre-optic nasendoscopy. (G)• Positron emission tomography–computed tomography (PET–CT), CT or MRI scan should be carried out at three months from completion of treatment to assess response. (R)• Multislice CT scan of head, neck and chest should be carried out in all patients and MRI scan whenever possible and specially in advanced cases with suspected recurrence. (R)• Surgery in form of nasopharyngectomy should be considered as a first line treatment of residual or recurrent disease at the primary site. (R)• Neck dissection remains the treatment of choice for residual or metastatic neck disease whenever possible. (R)• Re-irradiation should be considered as a second line of treatment in recurrent disease. (R)


Sign in / Sign up

Export Citation Format

Share Document